Amarin Corp Plcuk (AMRN) Accumulated Expenses (2010 - 2026)

Amarin Corp Plcuk (AMRN) posted quarterly Accumulated Expenses of $131.5 million for Q1 2026, up 12.63% YoY from $116.7 million in Q1 2025, and down 11.81% sequentially from $149.1 million in Q4 2025.

Amarin Corp Plcuk (AMRN) Accumulated Expenses (2010 - 2026) Analysis & Trends

Amarin Corp Plcuk has disclosed Accumulated Expenses across 17 years of filings, most recently posting $131.5 million for Q1 2026.

  • In Q1 2026, Accumulated Expenses rose 12.63% year-over-year to $131.5 million; the TTM figure through Mar 2026 stood at $131.5 million (up 12.63% YoY), while the FY2025 annual figure was $149.1 million, up 870.6% from the prior year.
  • Accumulated Expenses slipped to $131.5 million in Q1 2026, from $149.1 million in the prior quarter.
  • Over the last five years, Accumulated Expenses for AMRN reached as high as $243.1 million in Q2 2022 and fell as low as $3.6 million in Q4 2023.
  • The 5-year median for Accumulated Expenses is $154.4 million (2024), against an average of $145.1 million.
  • Annual changes were most pronounced in 2023 — Accumulated Expenses tumbled 82.33% — and 2025, when it surged 870.6%.
  • A 5-year view of Accumulated Expenses shows it stood at $20.3 million in 2022, then sank by 82.33% to $3.6 million in 2023, then jumped by 328.27% to $15.4 million in 2024, then surged by 870.6% to $149.1 million in 2025, then slipped by 11.81% to $131.5 million in 2026.
  • According to Business Quant data, Accumulated Expenses over the past three periods registered $131.5 million, $149.1 million, and $145.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn -
10 Amarin Corp Plcuk 5.17 Bn 5.00 Bn 17.77 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 131.49 Mn
Dec 31, 2025 149.10 Mn
Sep 30, 2025 145.52 Mn
Jun 30, 2025 141.24 Mn
Mar 31, 2025 116.75 Mn
Dec 31, 2024 15.36 Mn
Sep 30, 2024 161.05 Mn
Jun 30, 2024 176.16 Mn
Mar 31, 2024 154.44 Mn
Dec 31, 2023 3.59 Mn
Sep 30, 2023 211.30 Mn
Jun 30, 2023 214.60 Mn
Mar 31, 2023 183.26 Mn
Dec 31, 2022 20.30 Mn
Sep 30, 2022 192.00 Mn
Jun 30, 2022 243.06 Mn
Mar 31, 2022 207.62 Mn
Dec 31, 2021 3.56 Mn
Sep 30, 2021 289.68 Mn
Jun 30, 2021 226.55 Mn